Piper Alderman is pleased to have advised Microbiogen Pty Ltd (Microbiogen) and the selling shareholders on the sale of shares in Microbiogen to Novonesis, a global biosolutions company.
Our Intellectual Property & Technology team reflects on the year and the industry trends of 2025. The team also looks toward what the next 12 months may have in store.
Our Intellectual Property & Technology Team reflects on the year and the industry trends of 2024. The Team also looks forward to what the next 12 months may have in store.